PR Newswire02.22.18
Aesculap Inc. is pleased to announce the asset acquisition of Dextera Surgical Inc. Aesculap is an industry expert in providing comprehensive solutions and differentiated technologies to help meet the needs of the changing healthcare environment.
Dextera designs, manufactures, and markets proprietary medical devices for surgical procedures, including surgical staplers and innovative devices for coronary artery bypass graft (CABG) surgery. Aesculap will oversee operations in Redwood City, Calif. to continue the manufacturing and distribution of Dextera's products.
Through the acquisition, Aesculap expands its portfolio of premium solutions for beating heart coronary and video-assisted thoracic surgery. The innovative MicroCutter 5/80 stapler, PAS-Port proximal anastomosis system, C-Port distal anastomosis system and technology portfolio supports Aesculap's growth in the cardio-thoracic surgery market.
Dextera designs, manufactures, and markets proprietary medical devices for surgical procedures, including surgical staplers and innovative devices for coronary artery bypass graft (CABG) surgery. Aesculap will oversee operations in Redwood City, Calif. to continue the manufacturing and distribution of Dextera's products.
Through the acquisition, Aesculap expands its portfolio of premium solutions for beating heart coronary and video-assisted thoracic surgery. The innovative MicroCutter 5/80 stapler, PAS-Port proximal anastomosis system, C-Port distal anastomosis system and technology portfolio supports Aesculap's growth in the cardio-thoracic surgery market.
